X
Xiang Li
Researcher at Janssen Pharmaceutica
Publications - 39
Citations - 9364
Xiang Li is an academic researcher from Janssen Pharmaceutica. The author has contributed to research in topics: Population & Glaucoma. The author has an hindex of 21, co-authored 38 publications receiving 6400 citations. Previous affiliations of Xiang Li include National University of Singapore.
Papers
More filters
Journal ArticleDOI
Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis.
TL;DR: The global prevalence of primary open-angle glaucoma (POAG) and primary angle-closure glauComa (PACG) and the number of affected people in 2020 and 2040 are examined, disproportionally affecting people residing in Asia and Africa.
Journal ArticleDOI
Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis.
Wan-Ling Wong,Xinyi Su,Xiang Li,Chui Ming Gemmy Cheung,Ronald Klein,Ching-Yu Cheng,Tien Yin Wong +6 more
TL;DR: In this article, the authors did a systematic literature review to identify all population-based studies of age-related macular degeneration published before May, 2013, using retinal photographs and standardised grading classifications.
Journal ArticleDOI
Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression: A Randomized Clinical Trial.
Ella Daly,Madhukar H. Trivedi,Adam Janik,Honglan Li,Yun Zhang,Xiang Li,Rosanne Lane,Pilar Lim,Anna R. Duca,David Hough,Michael E. Thase,John Zajecka,Andrew Winokur,Ilona Divacka,Andrea Fagiolini,Wiesław Jerzy Cubała,István Bitter,Pierre Blier,Richard C. Shelton,Patricio Molero,Husseini K. Manji,Wayne C. Drevets,Jaskaran Singh +22 more
TL;DR: Continuation of esketamine nasal spray in addition to oral antidepressant treatment resulted in clinically meaningful superiority in delaying relapse compared with antidepressant plus placebo in patients with TRD in stable remission.
Journal ArticleDOI
Microvascular network alterations in the retina of patients with Alzheimer's disease.
Carol Y. Cheung,Yi Ting Ong,M. Kamran Ikram,Shin Yeu Ong,Xiang Li,Saima Hilal,Joseree-Ann S. Catindig,Narayanaswamy Venketasubramanian,Philip Yap,Dennis Seow,Christopher Chen,Christopher Chen,Tien Yin Wong +12 more
TL;DR: Whether quantitatively measured retinal microvascular parameters are associated with AD is determined by assessing the retina's noninvasive window to assess the microcirculation.
Journal ArticleDOI
Micropulse versus continuous wave transscleral diode cyclophotocoagulation in refractory glaucoma: a randomized exploratory study.
Maria Cecilia Aquino,Keith Barton,Keith Barton,Keith Barton,Anna Marie W T Tan,Chelvin C A Sng,Xiang Li,Seng Chee Loon,Paul T K Chew,Paul T K Chew +9 more
TL;DR: The aim of this study was to compare the efficacy and safety of micropulse and continuous wave diode transscleral cyclophotocoagulation in refractory glaucoma.